#clinical-trial-failure
#clinical-trial-failure

[ follow ]

Silicon Valley

Calif. biotech company lays off almost half of staff after 78% stock drop

Gossamer Bio laid off 48% of its workforce after its blood pressure drug study missed primary endpoints, causing a 78% stock price decline.

fromSFGATE

4 months ago

Business

Bay Area biotech company once worth $2 billion lays off half of its workers

Alector will lay off about half its staff after its Phase 3 drug latozinemab failed to slow dementia progression, prompting program discontinuation and leadership changes.

fromSFGATE

1 day ago

Silicon Valley

Calif. biotech company lays off almost half of staff after 78% stock drop

fromSFGATE

4 months ago

Business

Bay Area biotech company once worth $2 billion lays off half of its workers

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Novo Nordisk's stock dropped 22% weekly and 56% yearly after CagriSema trial failure and announced price cuts on flagship drugs, causing analyst downgrades and declining Reddit sentiment.

[ Load more ]

#clinical-trial-failure#clinical-trial-failure

Calif. biotech company lays off almost half of staff after 78% stock drop

Bay Area biotech company once worth $2 billion lays off half of its workers

Calif. biotech company lays off almost half of staff after 78% stock drop

Bay Area biotech company once worth $2 billion lays off half of its workers

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

#clinical-trial-failure
#clinical-trial-failure